(Public Health) Management of Ebola Disease. Aura Timen, MD, PhD. National Coordination Centre for Communicable Disease Control (LCI) CIb

Similar documents
Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2.

Ebola Q & A. # Question Answer Modified


CDC Support for Exit Screening and Lessons Learned for Preparedness

Ebola Facts. October 14, 2014

A surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014

Supplementary Appendix

RE: CIRCULAR 02/14 EBOLA - SOUTH AMERICAN COUNTRIES

Announcements. Please mute your phones and DO NOT place us on hold. Press *6 to mute/unmute your phone.

PROTECT YOURSELF PROTECT YOUR FAMILY PROTECT YOUR COMMUNITY from Ebola

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT

Ebola by the Numbers: Not a Small-scale Killer Anymore

Surveillance strategy during Phase 3 of the Ebola response

IHR Emergency Committee on the 2014 / 15 Ebola outbreak in West Africa

EBOLA AND PREPAREDNESS AT DENVER HEALTH. Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health

Clinical Case Management Guidelines of Ebola Virus Disease (EVD)

R&D for potential vaccines for the Ebola virus

Using Complete Blood Cell Counts to Diagnose Disease

UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES

DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88%

Daniel J. Mollura, MD Tara N. Palmore, MD Les R. Folio, DO David A. Bluemke, MD, PhD. Original Research n Special Report

Guidelines for the Medical Clearance of Designated Ebola Caregivers in US Hospitals

UNCLASSIFIED OPERATION UNITED ASSISTANCE SUMMARY Z October 14

Maine Ebola Response Plan. Jane Coolidge PhD, RN DHHS, Maine CDC, PHEP

BRIDGING PEOPLE AND TECHNOLOGY Why Population Health Matters

Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease

Modeling the Ebola Outbreak in West Africa, DRAFT Not for attribution or distribution

Management of Ebola virus disease: is environmental decontamination effective?

Transmitted from animals to humans. Transmitted humans-to-human by body fluid contact

EBOLA SITUATION REPORT

Reconsidering the Ethical Permissibility of the use of Unregistered Interventions against Ebola Virus Disease

Selection and use of Ebola in vitro diagnostic (IVD) assays

Laboratory Research Ethics, Conduct and Safety

arxiv: v4 [q-bio.pe] 2 Sep 2014

Responding to Ebola Virus Disease on Commercial Airlines

Classroom Discussion Guide on Ethics and Public Health Emergencies

EBOLA RESPONSE ROADMAP

Guidance Note H1402 Packaging and Transport of waste from suspect

Tropical Medicine & International Health

Laboratory Research Conduct & Safety: Biohazards and Biosafety. Environmental Health & Safety

Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation

Standard Project Report 2015

WFP West Africa Regional Bureau REGIONAL SPECIAL OPERATION SO

Learn more about why severe RSV disease APPROVED USE

EBOLA RESPONSE IN LIBERIA COMMUNITY HEALTH VOLUNTEERS

Louise Gresham PhD MPH Fondation Mérieux. Ebola Panel IOM 19 November 2014

BUDGET REVISION OF SO FOR APPROVAL BY THE EXECUTIVE DIRECTOR

Laboratory Research Conduct & Safety: Biohazards and Biosafety. Environmental Health & Safety

SITUATION REPORT EBOLA RESPONSE RESPONSE ROADMAP SITUATION ROADMAP REPORT

MEDICAL WASTE MANAGEMENT STUDY NOTES

An Investigation into the Existing Capacity and Screening Procedures for Ebola at Jomo Kenyatta International Airport, Nairobi

One Year Later, Where Does the U.S. Response to Ebola Stand?

Laboratory Risk Assessment Form. PART A: Research/Investigation. Principal Investigator: Department: Location of Research: Funding agency: Agent Used:

Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak

Enoxaparin (Lovenox )

The Journal of Infectious Diseases SUPPLEMENT ARTICLE

Diagnostics: Learning from successful experiences which made it to market. Mark Miller, MD Chief Medical Officer biomérieux France

Survey of Private Sector Pharmacies and Medicine Stores in Montserrado County, Liberia

Section 1: SUBSTANCE IDENTIFICATION AND SUPPLIER

Update from the Business Continuity Working Group

The response of research: from the field to the lab. K. Victoir PhD

b) Where is the Storage location(s)? (provide the location in the pharmacy, building and room numbers)

A GUIDE TO THIS REFLECTIONS B RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE

Verification of Environmental Cleaning & the Impact on Patient Safety

Atlantic County Division of Public Health Questions and Answers about Cyanide

IGRAs for Serial Testing of Healthcare Workers

COPING WITH BIOSAFETY IN EXTREME FIELD CONDITIONS?

Obtain a set of DNA sequences that includes the reference sample from Guinea and 15 Ebola DNA sequences from samples of patients in Sierra Leone.

TRAINING GOPACKAGE FOR EBOLA PRE-DEPLOYMENT PARTICIPANT HANDBOOK

UNIVERSITY OF TOLEDO HEALTH SCIENCE CAMPUS

Ebola Zaire Real-TM Handbook

Security Services A Workbook to record your training and personal development

New University of Lisbon Institute of Hygiene and Tropical Medicine

EBOLA crisis management In GUINEA

Dengue Hemorrhagic Fever: A Model for International Collaboration

Public health professionals, general target group

Effects of Antibiotic Treatment on the Results of Nested ACCEPTED. Polymerase Chain Reactions for Scrub Typhus

Barium Iron Oxide Nanoparticles (BaFe12O19) US Research Nanomaterials, Inc. Material Safety Data Sheet acc. to OSHA and ANSI

Zaire Ebola Virus. genesig Advanced Kit. Nucleoprotein (np) gene. 150 tests. Primerdesign Ltd. For general laboratory and research use only

SCHOOL OF PUBLIC HEALTH COLLEGE OF HEALTH SCIENCES UNIVERSITY OF GHANA KNOWLEDGE, ATTITUDES AND PERCEPTIONS OF COMMUNITY

Inactivating Zaire Ebolavirus in Whole Blood Thin Smears used for Malaria. Diagnosis

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication

CHOLERA CASE INVESTIGATION FORM

LEARN. about. Please see Important Safety Information on pages 3-5 and enclosed full Prescribing Information.

Sudan Ebola Virus. genesig Standard Kit. Nucleoprotein (np) gene. 150 tests. Primerdesign Ltd. For general laboratory and research use only

BGSU s Biosafety and Infectious Waste Safety Procedures. Environmental Health & Safety 1851 N. Research Drive Bowling Green, OH

Firms and Federal Labs Flock to Seek FDA Emergency Use Authorization for Ebola MDx Assays

Interim Technical Note The Use of Cholera Rapid Diagnostic Tests November 2016

EFFECTS OF INFRASTRUCTURE ON EBOLA VIRAL DISEASE

Biomedical Waste Handling and Disposal

MATERIAL SAFETY DATA SHEET

Analysis of DTRA Nano Silver Study

16S rdna Sequencing Diagnosis of Spirochetemia in Lyme and related Borrelioses

WHO STRATEGIC RESPONSE PLAN. West Africa Ebola Outbreak

Transcription:

(Public Health) Management of Ebola Disease Aura Timen, MD, PhD National Coordination Centre for Communicable Disease Control (LCI) CIb

Het hoe,wat en wie van de LCI Everybody knows that pestilences have a way of recurring in the world; yet somehow we find it hard to believe in ones that crash down on our heads from a blue sky. There have been as many plagues as wars in history; yet always plagues and wars take people equally by surprise. A. Camus. The Plague 30-1-2015 Het hoe en wat van de LCI 2

Ebola Symptoms: 2-21 days postexposure (8-10) Fever Severe headache Muscle pain Weakness Fatigue Diarrhea Source: CDC (www.cdc.gov) Vomiting Abdominal (stomach) pain Unexplained hemorrhage (bleeding, bruising) 20-30% bleeding 50% shock, multiple organ failure 3

Clinical Features of Ebola Virus Disease. Chertow DS et al. N Engl J Med 2014. DOI: 10.1056/NEJMp1413084

Ebola Symptoms: 2-21 days postexposure (8-10) Fever Severe headache Muscle pain Weakness Fatigue Diarrhea Vomiting Abdominal (stomach) pain Unexplained hemorrhage (bleeding, bruising) Transmission: Source: CDC (www.cdc.gov) direct contact (through broken skin or mucous membranes) with: blood or body fluids objects (like needles and syringes) contaminated 20-30% bleeding 50% shock, multiple organ failure with the virus infected fruit bats or primates Each case infects 1,5-2 others 5

Airborne transmission? Myths and facts hypothesized but not demonstrated in humans Ebola virus can be spread through airborne particles under experimental conditions in animals in the laboratory setting, non-human primates with heads placed in closed hoods have been exposed to and infected by nebulized aerosols of Ebola virus. not documented during human EVD outbreaks in settings such as hospitals or households. no studies to evaluate the risk of Ebola transmission during aerosolgenerating medical procedures (e.g., intubation, bronchoscopy) Review of Human-to Human transmission of Ebola Virus. US CDC 30-1-2015 6

Towner et al, JID, 2005

Review of Human-to-Human transmission of ebola virus, CDC www.cdc.gov

Outbreaks of Ebola, 1976-2014 Source: www.cdc.gov 30-1-2015 9

Ebola index case dec 2013 Sources: NEJM, The Wall Street Journal Acknowledgements: J van Dissel

Source: ECDC Liberia Sierra Leone Guinea 30-1-2015 11

30-1-2015 12

Ebola how many people could become infected in Africa? cknowledgements: van Dissel

WHO: key performance indicators, preliminary data www.who.int/csr/resources/publications/ebola/response-roadmap/en/ 30-1-2015 14

Ebola virus disease infections in health-care workers Cases Deaths Guinea* 88 46 Liberia* 315 157 Nigeria** 11 5 Sierra Leone* 128 102 Spain 1 0 USA*** 3 0 Total 546 310 30-1-2015 Ebola response road map, WHO. November 5, 2014 15

Ebola how many people have been treated outside of Africa? doctors without borders

Ebola facts levels of protective gear Sources: CDC, North Shore- LIJ; Nebraska Medical Center; New York Times

Passenger flows and probability of case importation Gomes et al, Plos, Currents Outbreaks Sept 2, 2014 30-1-2015 18

Risk assessment for Europe (RRA, ECDC) The risk of infection for residents and visitors through exposure in the community is low (if they adhere to the recommended precautions). Residents and visitors run a risk of exposure to EVD in healthcare facilities. The risk of Ebola virus spreading from an EVD patient who arrives in the EU as result of a planned medical evacuation is low when appropriate measures are strictly adhered to, but cannot be excluded in exceptional circumstances. If a symptomatic case of EVD presents in a EU Member State, secondary transmission to caregivers in the family and in healthcare facilities cannot be excluded. 19

Exit screening -WHO recommendation -Health form, temperature check, clinical assessment -In place in Guinea, Liberia and Sierra Leone -36,000 checks -77 refused boarding (no Ebola but other conditions) 2 Ebola cases undetected (because non symptomatic) Schiphol airport: information leaflet on self monitoring In Belgium: entry screening for direct flights 30-1-2015 Het hoe en wat van de LCI 20

Source: LCI Persons arrives during incubation period

Ebola triage at GP or ER 23 LCI-Cib/RIVM 11-2014

Hier in het ziekenhuis Assessment by clinician, Public health specialist and virologist Ebola suspicion!

STRICT ISOLATION, DIAGNOSTIC According to guidelines LCI, WIP

All hospitals: assessment of patient with suspicion of ebola Implementation triage on ER Routing suspected patient PPE Training personnel Procedures for referral to academic hospital 30-1-2015 26

Academic hospitals:admission of patient, ebola diagnosis + other causes of fever Implementation triage on ER, isolation! Routing suspected patient PPE Training personnel Procedures for admission in strict isolation Diagnostics, treatment 30-1-2015 27

4 selected academic hospitals: treatment of confirmed ebola case Implementation triage on ER, isolation! Routing suspected patient PPE Training personnel Procedures for admission in strict isolation Diagnostics, early and long term, treatment Procedures for waste disposal 30-1-2015 28

Symptomatic patient during flight, medical evacuation

What if a patient is symptomatic upon arrival? - Isolation procedures at airport - Notification airport medical services according to current procedures - Trained personnel - Notification public health service and LCI/RIVM - Ambulance transport (guidelines!) - Assessment upon admission in hospital 30-1-2015 30

What if the patient presents at the GP? 30-1-2015 31

Contact monitoring: 21 days post exposure, by the PHS (GGD) 30-1-2015 Het hoe en wat van de LCI 32

33

Ebola: consultation on ebola triage in The Netherlands Consultations 51 (till Nov 2) Ebola PCR diagnostics 3 consultation by Source: LCI-CIb, RIVM

Ebola available guidance documents The Netherlands LCI-CIb/RIVM guidance: Filovirus (ebola/marburg) Triage for GPs, ambulance, ER Case classification Monitoring contacts Transport (suspected) patient further detailed in AZN protocols Ebola PEP and early treatment Diagnostics Cleaning protocol for patient s house Procedure for deceased patient Procedure for waste management (joint guidelines Belgium-Netherlands) WIP-guidance: Viral hemorrhagic fever Strict isolation Additional advice ebola http://www.rivm.nl/onderwerpen/e/ebola

ECDC: RRA update 16 october confirmed case of Ebola in a Spanish HCW no evidence indicating that the healthcare-associated transmission resulted from a change in the transmissibility of the virus. the current recommended infection control measures remain appropriate, if strictly applied. transmission to healthcare workers can be prevented by the strict application of infection control measures as recommended by WHO. however, even when infection control measures are thoroughly applied, transmission to healthcare workers can still exceptionally occur as a result of a breach in the strict application of the infection control measures, when caring for an infectious patient, when involved in waste management or when removing PPE. 36

ECDC: RRA - Clinicians in the US report that patients in the advanced phase of the disease have an increased body fluid output of about five to ten liters per day, in combination with viral shedding in most body fluids (and skin). - -Virus was not, however, found in the dialysate of one patient where this was examined. - -No virus was detected on sampled surfaces of the toilet, bathroom and highly touched areas in the patient room. (https://extranet.who.int/ebola/#/home). 30-1-2015 37

Het hoe,wat en wie van de LCI He knew that the tale he had to tell could not be one of final victory. It could be only the record of what had to be done, and what assuredly would have to be done again in the neverending fight... A. Camus. The Plague 30-1-2015 Het hoe en wat van de LCI 38

THANK YOU! Acknowledgements J.T. van Dissel L. School Ebolateam LCI-CIb 30-1-2015 39